NCT02317367View on ClinicalTrials.gov

Self-Affirmation: Construct Validity

CompletedOBSERVATIONAL
Enrollment

3,112

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

January 15, 2020

Study Completion Date

August 27, 2021

Conditions
Risk Reduction Behavior
Trial Locations (1)

20892

National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT02317367 - Self-Affirmation: Construct Validity | Biotech Hunter | Biotech Hunter